Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion.

[1]  S. Moore,et al.  Roles of the neutrophil and other mediators in adult respiratory distress syndrome. , 1989, Mayo Clinic proceedings.

[2]  B. Seed,et al.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. , 1989, Science.

[3]  R. Kloner,et al.  “Reperfusion Injury” by Oxygen‐Derived Free Radicals?: Effect of Superoxide Dismutase Plus Catalase, Given at the Time of Reperfusion, on Myocardial Infarct Size, Contractile Function, Coronary Microvasculature, and Regional Myocardial Blood Flow , 1989, Circulation research.

[4]  P. J. Simpson,et al.  Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. , 1988, The Journal of clinical investigation.

[5]  G. Lobley,et al.  Changes in protein turnover in hypertrophying plantaris muscles of rats: effect of fenbufen--an inhibitor of prostaglandin synthesis. , 1987, Prostaglandins.

[6]  P. Braquet,et al.  Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. , 1987, Biochemical and biophysical research communications.

[7]  M. Weisfeldt,et al.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. , 1987, Circulation.

[8]  F. Snyder,et al.  Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. , 1987, Prostaglandins.

[9]  P. Chatelain,et al.  Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. , 1987, Circulation.

[10]  M. Weisfeldt,et al.  Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. , 1986, Circulation.

[11]  W. Nayler,et al.  Reperfusion injury: laboratory artifact or clinical dilemma? , 1986, Circulation.

[12]  P. Menasché,et al.  A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase. , 1986, The Journal of thoracic and cardiovascular surgery.

[13]  S. Kunkel,et al.  Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals. , 1986, Circulation.

[14]  S. Lemeshow,et al.  Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers. , 1986, The Journal of thoracic and cardiovascular surgery.

[15]  L. Greenfield,et al.  Prevention of free radical-induced myocardial reperfusion injury with allopurinol. , 1985, The Journal of thoracic and cardiovascular surgery.

[16]  B. Lucchesi,et al.  Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase , 1984, Circulation research.

[17]  L. Greenfield,et al.  Inhibition of surgically induced ischemia/reperfusion injury by oxygen free radical scavengers. , 1983, The Journal of thoracic and cardiovascular surgery.

[18]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[19]  M. Seeds,et al.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. , 1983, Journal of immunology.

[20]  M. Kirsh,et al.  Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. , 1982, The Journal of thoracic and cardiovascular surgery.

[21]  L. McManus,et al.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). , 1981, Journal of immunology.

[22]  J. O'flaherty,et al.  Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues. , 1981, Journal of immunology.

[23]  J. O'flaherty,et al.  1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. , 1981, The American journal of pathology.

[24]  R. Gunnar,et al.  Chemotactic activity in the coronary sinus after experimental myocardial infarction: effects of pharmacologic interventions on ischemic injury. , 1977, The American journal of cardiology.

[25]  Jennings Rb,et al.  EXPERIMENTAL ACUTE MYOCARDIAL INFARCTION; HISTOLOGIC AND HISTOCHEMICAL STUDIES OF EARLY MYOCARDIAL INFARCTS INDUCED BY TEMPORARY OR PERMANENT OCCLUSION OF A CORONARY ARTERY. , 1964 .

[26]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[27]  I. Fridovich.  The Biology of Oxygen Radicals: Threats and Defenses , 1988 .

[28]  M. Weisfeldt,et al.  Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. , 1987, Circulation.

[29]  D. Hanahan.  Platelet activating factor: a biologically active phosphoglyceride. , 1986, Annual review of biochemistry.